Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line

PLoS ONE - United States
doi 10.1371/journal.pone.0229712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)


Related search